New Jersey-based Tonix Pharmaceuticals Holding Corp. announced today a collaboration with the Kenya Medical Research Institute (KEMRI) to conduct a Phase 1 clinical study in Kenya to develop TNX-8011 as a vaccine to protect people against monkeypox and smallpox. This early-stage study is expected to start in the first half of 2023. Tonix has previously reported positive data from a monkeypox challenge clinical study in non-human primates.
Tonix Pharma (TNXP) Collaborates with Kenya Medical Research Institute to Develop TNX-801 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vaccine uptake changed after Uhuru led by example in the vaccination drive.He allocated more resources to fighting Covid, including strengthening healthcare.
Prof Matilu Mwau's study on human cardiovascular system using the African Rock Python was dropped due to lack of data on the number of African Rock Pythons in Kenya.